SEC Form 4 · accession 0001179110-15-012465
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank E Thomas
Officer — President & COO
Period of report
Aug 20, 2015
Accepted (ET)
Aug 21, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2015 | F | 2,363 | $61.71 | D | 106,946 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the reporting person's tax obligations with the vesting of 5,000 restricted stock units ("RSUs") on August 1, 2015. Due to the black-out policies implemented by AMAG Pharmaceuticals, Inc., the shares underlying such vested RSUs were not delivered to the reporting person until August 20, 2015, at which time 2,363 shares were withheld to satisfy the reporting person's applicable tax obligations.